Sales rise for blood-screening system kits, company reports

03/1/2012 | CBS MoneyWatch

Cerus reported it saw an increase in revenue in the fourth quarter due in part to higher sales of disposable kits used with its Intercept blood-screening system, which eliminates bacteria, viruses and parasites in donated platelets. The company said it is preparing to initiate two late-stage clinical trials involving its screening system for red blood cells.

View Full Article in:

CBS MoneyWatch

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY